Latest filing published 10 Jun 2026 for INCYTE CORP. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Otis W. Brawley (board member) discloses dealings in 3 companies, chiefly Agilent Technologies, Inc., Incyte Corp and Lyell Immunopharma, Inc. We count 15 filings; the first trade dates from 27 September 2021 and the latest from 8 June 2026.
No open-market sale appears; the market trades are 1 purchase worth €18k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 14 share grants.
The latest filing, published on 10 June 2026, reports a share grant in Incyte Corp. The most recent open-market purchase was published on 2 April 2025, 564 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations